GoodRx Holdings, Inc. (NASDAQ:GDRX) Q3 2023 Earnings Conference Call November 9, 2023 ET

Company Participants

Whitney Notaro - VP, IR

Scott Wagner - Interim CEO

Karsten Voermann - CFO

Raj Beri - COO

Conference Call Participants

Charles Rhyee - Cowen

Jailendra Singh - Truist

Scott Schoenhaus - KeyBanc

Lisa Gill - JPMorgan

Eric Sheridan - Goldman Sachs

Craig Hettenbach - Morgan Stanley

Stan Berenshteyn - Wells Fargo Securities

Daniel Grosslight - Citi

Robert Simmons - D.A. Davidson

Parker Snure - Raymond James

George Hill - Deutsche Bank

Jack Wallace - Guggenheim Partners

Operator

Ladies and gentlemen, thank you for standing by. And welcome to the GoodRx Third Quarter 2023 Earnings Call. [Operator instructions]. Please be advised that today's conference is being recorded.

I would now like to introduce your host for today’s call Whitney Notaro, Vice President of Investor Relations. Madam, you may begin.

Whitney Notaro

Thank you, operator. Good morning, everyone, and welcome to GoodRx's earnings conference call for the third quarter 2023. Joining me today are Scott Wagner, our Interim Chief Executive Officer, and Karsten Voermann, our Chief Financial Officer. Raj Beri, our Chief Operating Officer, will also be joining for the Q&A portion of today’s call.

Before we begin, I'd like to remind everyone that this call will contain forward-looking statements. All statements made on the call that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation, statements regarding management's plans, strategies, goals and objectives, our market opportunity, our anticipated financial performance, the ongoing impact of the former grocer issue on our business, underlying trends in our business, our potential for growth, collaborations and partnerships with third parties, anticipated impacts of the deprioritization of certain solutions under our Pharma Manufacturer Solutions offering, and our cost savings initiatives, our direct contracting approach with retailers, reliability of our deferred tax assets, and the expected impact from the macroeconomic environment on our business. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties, and other important factors. These factors may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements.

Factors discussed in the Risk Factors section of our Annual Report on Form 10-K for the year ended December 31, 2022, as updated by our quarterly report on Form 10-Q for the quarter ended September 30, 2023, and our other filings with the Securities and Exchange Commission, could cause actual results to differ materially from those indicated by the forward-looking statements made on this call. Any such forward-looking statements represent management's estimates as of the date of this call, and we disclaim any obligation to update these statements, even if subsequent events cause our views to change.